[Clinical efficacy and relative factors of dendritic cell-based tumor vaccination for prostate cancer: a systematic review and meta-analysis].

@article{Wu2013ClinicalEA,
  title={[Clinical efficacy and relative factors of dendritic cell-based tumor vaccination for prostate cancer: a systematic review and meta-analysis].},
  author={Kun Wu and Jun-song Meng and Azhati Baihetiya and Yu-Jie Wang},
  journal={Zhonghua nan ke xue = National journal of andrology},
  year={2013},
  volume={19 6},
  pages={545-50}
}
OBJECTIVE To evaluate the efficacy and safety of dendritic cell (DC)-based vaccines in the treatment of prostate cancer, and investigate the factors that influence the clinical benefit rate (CBR) of the vaccines. METHODS Based on pre-determined search criteria, we searched the Medline database for randomized controlled trials on DC-based vaccines immunotherapy of prostate cancer. We systematically analyzed the identified studies using RevMan 5.0 and SPSS 17.0 softwares. RESULTS Ten… CONTINUE READING